Commercialization Efforts definition

Commercialization Efforts shall have correlative meanings thereto.
Sample 1Sample 2
Commercialization Efforts means efforts (a) to commercialize all Barbed Suture Products for the indications for which the requisite governmental approval, including FDA clearance, has been granted, (b) to develop and obtain the requisite governmental approval, including FDA clearance, of the orthopedic indication of a Barbed Suture Product for tendon repair and (c) to commercially exploit the Company’s existing Company Proprietary Rights.
Sample 1Sample 2
Commercialization Efforts has the meaning described in Section 8.1.
Sample 1Sample 2

Examples of Commercialization Efforts in a sentence

  • Licensee shall use Commercially Reasonable Efforts to Develop and Commercialize Licensed Products in the Field in the Territory in accordance with this Agreement (including Section 4.01 (Development in the Field in the Territory) and Section 6.04 (Commercialization Efforts)).

  • Within 30 calendar days of the end of the second and fourth calendar quarters of each Earnout Year, Buyer shall deliver to the Stockholder Representative a report in reasonable detail setting forth for the preceding six calendar months, Product Revenues, Expenditures for Commercialization Efforts, Standard Income, Non-Standard Income and the status of FDA clearance for Barbed Suture Products in the field of tendon repair.

  • Further, with respect to the Company's obligations under Section 704 (Reasonable Diligence) and Section 505 (Reports by Company Regarding Commercialization Efforts), the Trustee shall make such inquiries and obtain such evidence as a prudent business person would do under the circumstances in order to monitor and verify the Company's proper performance of the Company's obligations pursuant to said Sections 704 and 505.

  • Stepp et al., “Turning the Page;” U.S. Department of Energy Office of Inspector General, “Audit Report: Technology Transfer and Commercialization Efforts at the Department of Energy’s National Laboratories (Washington, D.C.: DOE, 2014), 2; U.S. Government Accountability Office, “Clearer Priorities and Greater Use of Innovative Approaches Could Increase the Effectiveness of Energy Laboratories,” (Washington, D.C. GAO, 2009), 1.

  • Such Commercialization Efforts shall include, without limitation, the WEG Group evaluating and pursuing target markets, identified at its sole discretion, taking into account the competitive landscape, pricing, necessary in-country resources and financing solutions and methods to best satisfy the needs of customers while maintaining the profitability goals from time to time established by the WEG Group for its commercialization of the 2.X Turbines.

  • Reasonable Commercialization Efforts - Because of the public interest that pervades JAYNSTEIN LLC research programs, any license entered into by JAYNSTEIN LLC will embody a clause permitting cancellations thereof if reasonable commercial use of the licensed invention or copyrighted material is not being made or diligently attempted by the licensee.

  • The foregoing is not intended to relieve the WEG Group of any liability or obligation that it may otherwise have under this Agreement nor limit the rights of NPS to pursue rights or remedies for any breach of contract other than, in each case, those relating to the WEG Group’s Commercialization Efforts.

  • Russia’s Innovation System and Commercialization Efforts 114Challenges in Russia’s Innovation System 120Human Capital 124Russia’s Intellectual Property Legal Framework 128Early-stage Financing 136References 139Annex A: The World Bank Enterprise Survey – Data and Methodology 141Annex B: The Agricultural Sector in the Russian Federation 143Annex 1A: A Note on the Gravity Model 151Annex 1B: An Extended Version of the Product-space Analysis.

  • Commencing upon Janssen obtaining first Regulatory Approval (including, for clarity, pricing and reimbursement approvals that Janssen determines in its discretion are necessary or desirable to obtain, regardless of whether or not required by Applicable Law) for a Licensed Product in any Major Market Country, Janssen shall use Diligent Commercialization Efforts during the applicable Royalty Term to Commercialize a Licensed Product in Major Market Countries where Regulatory Approval has been obtained.

  • Supporting Private Sector Commercialization Efforts In addition to investing in research and development and helping to expand U.S. manufacturing capacity, the government often has a role to play in commercializing emerging technologies, particularly where private financing is not sufficiently available to support investment at commercial scale.

Related to Commercialization Efforts

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Development Activities means those activities which are normally undertaken for the development, construction, repair, renovation, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Commercializing means to engage in Commercialization and “Commercialized” has a corresponding meaning.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Commercialize or “Commercialization” means the marketing, promotion, sale (and offer for sale or contract to sell), distribution, importation or other commercial exploitation (including pricing and reimbursement activities) for a Product in the Territory. Commercialization shall include commercial activities conducted in preparation for Product launch.

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Development Plan has the meaning set forth in Section 3.2.

  • Commercialise means to promote, market, distribute, sell and/or otherwise commercialise a product, and Commercialising and Commercialisation shall be construed accordingly;

  • Development Activity means any activity defined as Development which will necessitate a Floodplain Development Permit. This includes buildings, structures, and non-structural items, including (but not limited to) fill, bulkheads, piers, pools, docks, landings, ramps, and erosion control/stabilization measures.

  • Development Program means the implementation of the development plan.

  • Diligent Efforts means, with respect to a Party’s obligations hereunder, the carrying out of obligations or tasks in a sustained manner consistent with the efforts a Party devotes to a research, development or marketing project for a pharmaceutical product or products of similar market potential, profit potential or strategic value resulting from its own research efforts, based on conditions then prevailing, which efforts shall in any event be no less than those which would be considered reasonable in the pharmaceutical or biotechnology industries.

  • Commercialization Costs means the out-of-pocket costs and expenses incurred by Adapt or its Affiliates directly attributable to, or reasonably allocable to, the Commercialization of a Product. Commercialization Costs for a Product shall include, preparation of promotional, advertising, communication, medical, and educational materials relating to the Product and other Product literature and selling materials, activities directed to marketing of the Product, including purchase of market data, development and conduct of market research, advertising, public relations, public affairs and other communications with Third Parties regarding the Product; development and conduct of sales force training (including materials, programs and travel to and attendance at training programs) for medical representatives responsible for promoting the Product; and development and maintenance of sales bulletins, call reporting and other monitoring/tracking, sales force targeting, validation and alignment programs and documentation.

  • Joint Commercialization Committee or “JCC” has the meaning set forth in Section 3.4 (Joint Commercialization Committee).

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Commercialized shall have corresponding meanings.

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Development Plans means a coherent set of operations defined and financed exclusively by the OCTs in the framework of their own policies and strategies of development, and those agreed upon between an OCT and the Member State to which it is linked;

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Research Program has the meaning set forth in Section 3.1.

  • Licensed Product means a product or part of a product in the Licensed Field of Use: (A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or (B) which is made with, uses or incorporates any Technology.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Medical Affairs Activities means, with respect to any country or other jurisdiction in the Territory, the coordination of medical information requests and field based medical scientific liaisons with respect to Licensed Compounds or Licensed Products, including activities of medical scientific liaisons and the provision of medical information services with respect to a Licensed Compound or Licensed Product.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Research Program Term has the meaning set forth in Section 2.2.